For research use only. Not for therapeutic Use.
EM127（Cat No.:I042857）is an investigational compound being studied for its potential use in treating autoimmune diseases, particularly rheumatoid arthritis and other inflammatory conditions. It functions as a selective inhibitor targeting specific pathways involved in immune cell activation and inflammatory responses. By modulating immune system activity, EM127 aims to reduce inflammation and alleviate symptoms associated with autoimmune disorders, such as joint pain and swelling. Preclinical studies suggest that it may offer a novel approach for managing chronic inflammatory conditions, and further clinical trials are underway to evaluate its safety and efficacy in humans.
| CAS Number | 1886879-71-5 |
| Synonyms | N-[1-(2-chloroacetyl)piperidin-4-yl]-5-cyclopropyl-1,2-oxazole-3-carboxamide |
| Molecular Formula | C14H18ClN3O3 |
| Purity | ≥95% |
| IUPAC Name | N-[1-(2-chloroacetyl)piperidin-4-yl]-5-cyclopropyl-1,2-oxazole-3-carboxamide |
| InChI | InChI=1S/C14H18ClN3O3/c15-8-13(19)18-5-3-10(4-6-18)16-14(20)11-7-12(21-17-11)9-1-2-9/h7,9-10H,1-6,8H2,(H,16,20) |
| InChIKey | OENTXAYVUCLRJQ-UHFFFAOYSA-N |
| SMILES | C1CC1C2=CC(=NO2)C(=O)NC3CCN(CC3)C(=O)CCl |
